Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells

Biomaterials

Volumn 24, Issue 25, 2003, Pages 4671-4679

  Kim, Hyongbum ^a   Kim, Hyun Woo ^a   Suh, Hwal ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Ascorbate 2 phosphate; Dexamethasone; Mesenchymal stem cells; Osteogenesis; Poly(D,L lactide co glycolide)

Indexed keywords

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ORGANIC COMPOUNDS; ORTHOPEDICS; SCAFFOLDS;

MESENCHYMAL STEM CELLS (MSC);

BONE;

ASCORBIC ACID 2 PHOSPHATE; BIOMATERIAL; DEXAMETHASONE; POLYGLACTIN;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE TISSUE; CELL CULTURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG EFFECT; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; KINETICS; MESENCHYME CELL; MINERALIZATION; NONHUMAN; PARTICULATE MATTER; POROSITY; PRIORITY JOURNAL; STEM CELL; SUSTAINED DRUG RELEASE; TEMPERATURE DEPENDENCE; TISSUE ENGINEERING; WATER TRANSPORT;

EID: 0041887291     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(03)00358-2     Document Type: Article

References (48)

1. Rose F., Oreffo R. Bone tissue engineering. hope vs. hype Biochem Biophys Res Commun. 292:2002;1-7.
2. Caplan A.I., Bruder S.P. Mesenchymal stem cells. building blocks for molecular medicine in the 21st century Trends Mol Med. 7:2001;259-264. Ishaug S.L., Crane G.M., Miller M.J., Yasko A.W., Yaszemski M.J., Mikos A.G. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res. 36:1997;17-28.
3. Ishaug S.L., Crane G.M., Miller M.J., Yasko A.W., Yaszemski M.J., Mikos A.G. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res. 36:1997;17-28.
4. Petite H., Viateau V., Bensaid W., Meunier A., Pollak C., Bourguignon M., Oudina K., Sedel L., Guillemin G. Tissue-engineered bone regeneration. Nature. 18:2000;959-962.
5. Shang Q, Wang Z, Liu W, Shi Y, Cui L, Cao Y. Tissue-engineered bone repair of sheep cranial defects with autologous bone marrow stromal cells. J Craniofac Surg 2001;6:586-93 (discussion 94-5).
6. Jaiswal N., Haynesworth S.E., Caplan A.I., Bruder S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem. 64:1997;295-312.
7. Sikavitsas V.I., Bancroft G.N., Mikos A.G. Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J Biomed Mater Res. 62:2002;136-148.
8. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosaca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science. 284:1999;143-147.
9. Lennon D.P., Haynesworth S.E., Arm D.M., Baber M.A., Caplan A.I. Dilution of human mesenchymal stem cells with dermal fibroblasts and the effects on in vitro and in vivo osteochondrogenesis. Dev Dyn. 219:2000;50-62.
10. Maniatopolous C., Sodek J., Melcher A.H. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res. 254:1988;317-330.
11. Bellows C.G., Aubin J.E., Heersche J.N.M., Antosz N.M. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int. 38:1986;143-154.
12. Ecarot-Charrier B., Glorieux F.H., van der Rest M., Pereira G. Osteoblasts isolated from mouse calvaria inititate matrix mineralization in culture. J Cell Biol. 96:1983;639-643.
13. Tenenbaum HC. Role of organic phosphate in mineralization of bone in vitro. J Dent Res 1981;60 Spec No. C:1586-9.
14. Gundle R., Joyner C., Triffitt J. Human bone tissue formation in diffusion chamber culture in vivo by bone-derived cells and marrow stromal fibroblastic cells. Bone. 16:1995;597-601.
15. Yoshikawa T., Ohgushi H., Akahane M., Tamai S., Ichijima K. Analysis of gene expression in osteogenic cultured marrow/hydroxyapatite construct implanted at ectopic sites. a comparison with the osteogenic ability of cancellous bone J Biomed Mater Res. 41:1998;568-573.
16. Haynesworth S., Goshima J., Goldberg V., Caplan A. Characterization of cells with osteogenic potential from human marrow. Bone. 13:1992;81-88.
17. Zawicki D.F., Jain R.K., Schmid-Schoenbein G.W., Chien S. Dynamics of neovascularization in normal tissue. Microvasc Res. 21:1981;27-47.
18. Winn SR, Schmitt JM, Buck D, Hu Y, Grainger D, Hollinger JO. Tissue-engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats. J Biomed Mater Res 1999.
19. Ziegler J., Mayr-Wohlfart U., Kessler S., Breitig D., Gunther K.P. Adsorption and release properties of growth factors from biodegradable implants. J Biomed Mater Res. 59:2002;422-428.
20. 2. J Control Rel. 66:2000;177-185.
21. Murphy W.L., Peters M.C., Kohn D.H., Mooney D.J. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials. 21:2000;2521-2527.
22. Shea L.D., Smiley E., Bonadio J., Mooney D.J. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol. 17:1999;551-554.
23. Sheridan M.H., Shea L.D., Peters M.C., Mooney D.J. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Rel. 64:2000;91-102.
24. Whang K., Goldstick T.K., Healy K.E. A biodegradable polymer scaffold for delivery of osteotropic factors. Biomaterials. 21:2000;2545-2551.
25. Hu Y., Hollinger J.O., Marra K.G. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds. J Drug Target. 9:2001;431-438.
26. Meese T.M., Hu Y., Nowak R.W., Marra K.G. Surface studies of coated polymer microspheres and protein release from tissue-engineered scaffolds. J Biomater Sci Polym Ed. 13:2002;141-151.
27. Mikos A.G., Thorsen A.J., Czerwonka L.A., Bao Y., Langer R., Winslow D.N., Vacanti J.P. Preparation and characterization of poly(L-lactic acid) foams. Polymer. 35:1994;1068-1077.
28. Lu L., Peter S.J., Lyman M.D., Lai H.L., Leite S.M., Tamada J.A., Vacanti J.P., Langer R., Mikos A.G. In vitro degradation of porous poly(L-lactic acid) foams. Biomaterials. 21:2000;1595-1605.
29. Suh H., Hwang Y., Song M., Lee W., Han C., Park J. Behaviors of osteoblast-like cell (MC3T3-E1) on collagen grafted porous poly L-lactic acid (PLLA) membranes with various pore sizes. Biomater Res. 4:2000;37-44.
30. Lamiable D., Vistelle R., Millart H., Sulmont V., Fay R., Caron J., Choisy H. High-performance liquid chromatographic determination of dexamethasone in human plasma. J Chromatogr. 378:1986;486-491.
31. Sakai T., Murata H., Ito T. High-performance liquid chromatographic analysis of ascorbyl-2-phosphate in fish tissues. J Chromatogr B Biomed Appl. 685:1996;196-198.
32. Lincoff A.M., Furst J.G., Ellis S.G., Tuch R.J., Topol E.J. Sustained local delivery of a dexamethasone by a novel intravascular eluting stent to prevent restenosis in porcine coronary injury model. J Am Coll Cardiol. 29:1997;808-816.
33. Yoon J.J., Park T.G. Degradation behaviors of biodegradable macroporous scaffolds prepared by gas foaming of effervescent salts. J Biomed Mater Res. 55:2001;401-408.
34. Hickey T., Kreutzer D., Burgess D.J., Moussy F. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials. 23:2002;1649-1656.
35. Solchaga L.A., Johnstone B., Yoo J.U., Goldberg V.M., Caplan A.I. High variability in rabbit bone marrow-derived mesenchymal cell preparations. Cell Transplant. 8:1999;511-519.
36. Mikos A.G., Lyman M.D., Freed L.E., Langer R. Wetting of poly(L-lactic acid) and poly(D,L-lactic-co-glycolic acid) foams for tissue culture. Biomaterials. 15:1994;55-58.
37. Lu Y., Riyanto N., Weavers L. Sonolysis of synthetic sediment particles. particle characteristics affecting particle dissolution and size reduction Ultrason Sonochem. 9:2002;181-188.
38. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 203:2000;1-60.
39. Costantino H., Firouzabadian L., Hogeland K., Wu C., Beganski C., Carrasquillo K., Cordova M., Griebenow K., Zale S., Tracy M. Protein spray-freeze drying. Effect of atomization conditions on particle size and stability. Pharm Res. 17:2000;1374-1383.
40. Rogers T., Hu J., Yu Z., Johnston K., Williams Rr. A novel particle engineering technology. spray-freezing into liquid Int J Pharm. 242:2002;93-100.
41. Costantino H., Firouzabadian L., Wu C., Carrasquillo K., Griebenow K., Zale S., Tracy M. Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability. J Pharm Sci. 91:2002;388-395.
42. Park S.N., Park J.C., Kim H.O., Song M.J., Suh H. Characterization of porous collagen/hyaluronic acid scaffold modified by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide cross-linking. Biomaterials. 23:2002;1205-1212.
43. Mu L., Feng S. Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J Control Rel. 76:2001;239-254.
44. Rhine W., Hsieh D., Langer R. Polymers for sustained macromolecule release. procedures to fabricate reproducible delivery systems and control release kinetics J Pharm Sci. 69:1980;265-270.
45. Siegel R., Langer R. A new Monte-Carlo approach to diffusion in constricted porous geometries. J Colloid Interface Sci. 109:1986;426-440.
46. Berner B., Dinh S. Fundamental concepts in controlled release. Kydonieus A. Treatise on controlled drug delivery. 1992;1-35 Marcel Dekker Inc, New York.
47. Sandor M., Enscore D., Weston P., Mathiowitz E. Effect of protein molecular weight on release from micron-sized PLGA microspheres. J Control Rel. 76:2001;297-311.
48. Park S., Oreffo R., Triffitt J. Interconversion potential of cloned human marrow adipocytes in vitro. Bone. 24:1999;549-554.